FDA ban of generic oxycodone calls into question Health Canada’s approval
Health Canada is facing increased criticism for its approval of generic oxycodone after the US Food and Drug Administration (FDA) decided to ban generic versions of the drug that has been widely abused across North America. The FDA made its landmark ruling just days before Purdue Pharma’s patent on the original time-release formula of OxyContin was set to expire Apr. 23.
June 11, 2013 | Canadian Medical Association Journal News | News Article | Associated Research
Cholesterol-lowering statin drugs raise Type 2 diabetes risk, Health Canada warns
Health Canada has updated the labeling for commonly prescribed cholesterol-lowering drugs called statins to warn users they may be at a small increased risk of developing diabetes. The department announced the change on Thursday; 11 months after the U.S. Food and Drug Administration took similar action.
January 24, 2013 | The Globe and Mail | News Article
Painkillers increase risk of car crashes, study finds
People who take everyday doses of painkillers have a 20-to-40-per-cent greater risk of crashing their cars, a Canadian study shows. While that is a significantly lesser risk than driving while impaired by alcohol, patients and prescribers alike should be aware of the potential impact of opioid-based pain medication on their safety, researchers say.
January 14, 2013 | The Globe and Mail | News Article | Publication | Policy Research Minute | Clinical Research Minute | Patient Research Minute
Opioid painkillers may increase car accident risk
Study first to show driving risk tied to use of drugs like morphine in real world.
January 14, 2013 | CBC News | News Article | Publication | Policy Research Minute | Clinical Research Minute | Patient Research Minute
Archive: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | Older